Where does Biogemma rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biogemma ranks #31,027 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biogemma hold?

Biogemma holds 8 US utility patents granted between 2015 and 2020, spanning 18 technology areas.

What is Biogemma's Innovation Score?

Biogemma has an Innovation Score of 31.6 out of 100 (38th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Biogemma's patent grant rate increasing or decreasing?

Biogemma's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Biogemma's patents?

Biogemma's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biogemma patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biogemma

Q: What technology areas does Biogemma focus on?

Biogemma's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 3 patents, ranking #2,438 of 4,144 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 18 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biogemma ranks #31,027 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 18 technology areas.

#31,027
of 49,997 US assignees by volume: 38th percentile
by Innovation Score (31.6/100): 15.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31027 · Foreign Corporation #31,027 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,027/49,997
PHOTO-FINISH Bilberry SAS
CPC-FOCUS C12N · 18 areas
INNOV-THIN 31.6/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bilberry SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biogemma’s 31.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (24%) Velocity 0.0 pts (0%) Breadth 15.0 pts (47%) Claim depth 9.0 pts (28%)

Qualcomm Incorporated · highest

85
Biogemma · this assignee

32
3D Lighting… · lowest

7

What this shows Biogemma's Innovation Score is 31.6/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biogemma?

Each dot is one of Biogemma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biogemma’s own 15.0 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biogemma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biogemma's grants concentrate

Biogemma is a focused PatentsView assignee: 18 CPC subclasses with 37.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2017. By volume, Biogemma sits between Bilberry SAS and Biomune Company.

Bilberry SAS

8
Bioalpha

8
Biodiscovery NEW…

8
Biofridge

8
Bioincept

8
Biointeractions

8
Biomay

8
Biomune

8
Biogemma ◀

8

What this shows Biogemma holds 8 patents at rank #30,994, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biogemma

By rank, the assignees closest to #30,994 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Biogemma's primary technology class.

Biogemma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 38th percentile higher than 38% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biogemma patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	25.0%
2017	1	12.5%
2019	1	12.5%
2020	4	50.0%

Which technologies does Biogemma patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G06T - Image Data Processing OR Generation, IN General 3

A01D - HARVESTING; Mowing 2

H04N - Pictorial Communication, e.g. Television 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A01G - HORTICULTURE; Cultivation OF Vegetables, Flowers, Rice, Fruit, Vines, Hops OR SEAWEED; FORESTRY; Watering 2

C07K - Peptides 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 1

G02B - Optical Elements, Systems OR Apparatus 1

G03B - Apparatus OR Arrangements FOR Taking Photographs OR FOR Projecting OR Viewing THEM; Apparatus OR Arrangements Employing Analogous Techniques Using Waves Other Than Optical WAVES; Accessories Therefor 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

G06V - Image OR Video Recognition OR Understanding 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biogemma's patent record in context - here's where to go next.

Biogemma's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 37.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #31,027 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biogemma against Bilberry SAS, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.